130 related articles for article (PubMed ID: 37306157)
1. Refractory livedoid vasculopathy successfully treated with baricitinib.
Peñuelas Leal R; Grau Echevarría A; Martínez Domenech Á; Labrandero Hoyos C; Zaragoza Ninet V; Sanchez Carazo JL; Alegre de Miquel V
Int J Dermatol; 2023 Nov; 62(11):e608-e610. PubMed ID: 37306157
[No Abstract] [Full Text] [Related]
2. Baricitinib is potentially effective in the treatment of refractory livedoid vasculopathy.
Han Y; Tu P
Front Immunol; 2022; 13():1008392. PubMed ID: 36389811
[TBL] [Abstract][Full Text] [Related]
3. Refractory livedoid vasculopathy in a child successfully treated with baricitinib.
Zhang H; Chen J; Wu N; Chen H; Liu Y
Dermatol Ther; 2022 Aug; 35(8):e15659. PubMed ID: 35726859
[No Abstract] [Full Text] [Related]
4. Refractory livedoid vasculopathy successfully treated with baricitinib.
Xiao Y; Wang Y; Gu Y; Xia D; Li W
Int J Dermatol; 2023 Sep; 62(9):1204-1205. PubMed ID: 36349427
[No Abstract] [Full Text] [Related]
5. Efficacy of an anti-TNF-alpha agent in refractory livedoid vasculopathy: a retrospective analysis.
Gao Y; Jin H
J Dermatolog Treat; 2022 Feb; 33(1):178-183. PubMed ID: 32116074
[TBL] [Abstract][Full Text] [Related]
6. Adalimumab in Treating Refractory Livedoid Vasculopathy.
Huang XW; Zheng HX; Wang ML; He WM; Feng MX; Zeng K; Li L
Vaccines (Basel); 2022 Apr; 10(4):. PubMed ID: 35455298
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Livedoid Vasculopathy With Baricitinib.
Song X; Tu P
JAMA Dermatol; 2022 May; 158(5):587-589. PubMed ID: 35353137
[No Abstract] [Full Text] [Related]
8. A Case of Livedoid Vasculopathy Successfully Treated with Sulodexide.
Song CH; Shin DS; Jang JW; Kim TL; Kim YG; Kim JS; Seo HM
Ann Dermatol; 2020 Dec; 32(6):508-511. PubMed ID: 33911794
[TBL] [Abstract][Full Text] [Related]
9. Livedoid vasculopathy in a patient with lupus anticoagulant and MTHFR mutation: treatment with low-molecular-weight heparin.
Abou Rahal J; Ishak RS; Otrock ZK; Kibbi AG; Taher AT
J Thromb Thrombolysis; 2012 Nov; 34(4):541-4. PubMed ID: 22592843
[TBL] [Abstract][Full Text] [Related]
10. Dermoscopic features of livedoid vasculopathy.
Hu SC; Chen GS; Lin CL; Cheng YC; Lin YS
Medicine (Baltimore); 2017 Mar; 96(11):e6284. PubMed ID: 28296736
[TBL] [Abstract][Full Text] [Related]
11. Livedoid vasculopathy with underlying subcutaneous necrotizing venulitis in an asymptomatic hepatitis B virus carrier: is livedoid vasculopathy a true nonvasculitic disorder?
Ishibashi M; Miyamoto J; Nagasaka T; Chen KR
Am J Dermatopathol; 2009 May; 31(3):293-6. PubMed ID: 19384073
[TBL] [Abstract][Full Text] [Related]
12. Livedoid vasculopathy and recurrent thrombosis in a patient with lupus: seronegative antiphospholipid syndrome?
Sopeña B; Pérez-Rodríguez MT; Rivera A; Ortiz-Rey JA; Lamas J; Freire-Dapena MC
Lupus; 2010 Oct; 19(11):1340-3. PubMed ID: 20659971
[TBL] [Abstract][Full Text] [Related]
13. Penile Livedoid Vasculopathy: First Reported Case.
Hallak A; Bennett W; Tanbir MA; Donthamsetty SR; Vincent B
Case Rep Vasc Med; 2023; 2023():6920383. PubMed ID: 37440957
[TBL] [Abstract][Full Text] [Related]
14. Livedoid vasculopathy associated with heterozygous protein C deficiency.
Boyvat A; Kundakçi N; Babikir MO; Gürgey E
Br J Dermatol; 2000 Oct; 143(4):840-2. PubMed ID: 11069468
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the German DRG data for livedoid vasculopathy and calciphylaxis.
Renner R; Dissemond J; Goerge T; Hoff N; Kröger K; Erfurt-Berge C
J Eur Acad Dermatol Venereol; 2017 Nov; 31(11):1884-1889. PubMed ID: 28252815
[TBL] [Abstract][Full Text] [Related]
16. Intractable livedoid vasculopathy successfully treated with hyperbaric oxygen.
Yang CH; Ho HC; Chan YS; Liou LB; Hong HS; Yang LC
Br J Dermatol; 2003 Sep; 149(3):647-52. PubMed ID: 14511004
[TBL] [Abstract][Full Text] [Related]
17. Livedoid vasculopathy - A diagnostic and therapeutic challenge.
Burg MR; Mitschang C; Goerge T; Schneider SW
Front Med (Lausanne); 2022; 9():1012178. PubMed ID: 36262273
[TBL] [Abstract][Full Text] [Related]
18. Pain Management Options in a Patient with Livedoid Vasculopathy and Peripheral Neuropathy.
Palanisamy N; Chinnappan J; Bachuwa G
Eur J Case Rep Intern Med; 2023; 10(1):003727. PubMed ID: 36819654
[TBL] [Abstract][Full Text] [Related]
19. Systemic lupus erythematosus with refractory ulcerated livedoid vasculopathy: Successful treatment with intravenous immunoglobulin and warfarin.
Yoshioka K; Tateishi C; Kato H; Chen KR
Clin Case Rep; 2018 Nov; 6(11):2045-2047. PubMed ID: 30455888
[TBL] [Abstract][Full Text] [Related]
20. Medium-pressure hyperbaric oxygen therapy for livedoid vasculopathy.
Herrera-Sánchez A; Madriagal-Alvarado MJ; Moncayo G; Verdini F
Medicina (B Aires); 2022; 82(4):613-616. PubMed ID: 35904919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
